Gilead Sciences Announces $24 Million in Grants to Help End the HIV Epidemic for Everyone, Everywhere Pharmaceutical Investing
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis Pharmaceutical Investing
AUPH INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
Knight Therapeutics Inc. places on The Globe and Mail's third-annual Women Lead Here benchmark of executive gender diversity Pharmaceutical Investing
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® for Patients With Microsatellite Instability-High or Mismatch Repair Deficient Tumors in Five Different Types of Cancer Life Science Investing News
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® Plus Chemotherapy, With or Without Bevacizumab, as Treatment for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 Life Science Investing News
Bristol Myers Squibb Announces New Prescription Drug User Fee Act Goal Date for Reblozyl® Supplemental Biologics License Application Pharmaceutical Investing
AUPH INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
Long Term Holders of Abbott Laboratories Contact Johnson Fistel for Information Regarding Investigation Pharmaceutical Investing
Abbott's FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin Pharmaceutical Investing
Knight Therapeutics Reports Fourth Quarter and Year-End 2021 Results and Provides 2022 Revenue Guidance Pharmaceutical Investing
Universal Ibogaine to Participate in the 2022 Virtual Growth Conference - Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT Pharmaceutical Investing
